• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病与心脏。

Diabetes mellitus and the heart.

机构信息

Multidisciplinary Cardiovascular Research Centre, The University of Leeds, Leeds, UK.

出版信息

Int J Clin Pract. 2012 Jul;66(7):640-7. doi: 10.1111/j.1742-1241.2012.02924.x.

DOI:10.1111/j.1742-1241.2012.02924.x
PMID:22698416
Abstract

Diabetes mellitus is a risk factor for the development of coronary artery disease and chronic heart failure. When carefully screened for, diabetes or prediabetic disorders, are present in the majority of patients with clinically manifest ischaemic heart disease, and confer a major adverse impact upon morbidity and mortality. Important therapeutic modifications are required in the management of coronary artery disease and chronic heart failure associated with diabetes, and vice versa. However, despite optimal management, aided by recent landmark trials solely recruiting patients with diabetes, outcomes for patients with diabetes and heart disease remain poor. This review outlines the epidemiology, pathogenesis and management of diabetic heart disease, along with highlighting the many gaps in the evidence-base and suggesting future research priorities.

摘要

糖尿病是冠状动脉疾病和慢性心力衰竭发展的一个危险因素。在对临床上表现为缺血性心脏病的大多数患者进行仔细筛查时,会发现糖尿病或糖尿病前期障碍,这会对发病率和死亡率产生重大不利影响。需要对与糖尿病相关的冠状动脉疾病和慢性心力衰竭的管理进行重要的治疗修改,反之亦然。然而,尽管最近的标志性试验仅招募了糖尿病患者,在最佳管理的帮助下,糖尿病和心脏病患者的治疗结果仍然很差。本综述概述了糖尿病性心脏病的流行病学、发病机制和管理,同时强调了证据基础中的许多空白,并提出了未来的研究重点。

相似文献

1
Diabetes mellitus and the heart.糖尿病与心脏。
Int J Clin Pract. 2012 Jul;66(7):640-7. doi: 10.1111/j.1742-1241.2012.02924.x.
2
Heart Failure.心力衰竭。
Ann Intern Med. 2018 Jun 5;168(11):ITC81-ITC96. doi: 10.7326/AITC201806050.
3
Lessons Learned and Insights Gained in the Design, Analysis, and Outcomes of the COMPANION Trial.在 COMPANION 试验的设计、分析和结果中获得的经验教训和见解。
JACC Heart Fail. 2016 Jul;4(7):521-535. doi: 10.1016/j.jchf.2016.02.019. Epub 2016 Jun 8.
4
ICDs Are Still an Effective Therapy to Prevent Sudden Cardiac Death in Heart Failure.植入式心脏除颤器仍是预防心力衰竭患者心源性猝死的有效疗法。
JACC Heart Fail. 2019 Oct;7(10):907-910. doi: 10.1016/j.jchf.2019.08.001. Epub 2019 Sep 11.
5
Impact of active smoking on the immature platelet fraction and its relationship with the extent of coronary artery disease.主动吸烟对血小板未成熟分数的影响及其与冠状动脉疾病严重程度的关系。
Eur J Clin Invest. 2020 Feb;50(2):e13181. doi: 10.1111/eci.13181. Epub 2020 Jan 18.
6
Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.基于证据的药物治疗和血运重建:糖尿病和冠心病患者管理的有力工具:欧洲心脏调查糖尿病与心脏报告
Eur J Cardiovasc Prev Rehabil. 2008 Apr;15(2):216-23. doi: 10.1097/HJR.0b013e3282f335d0.
7
Management of Heart Failure Patient with CKD.慢性肾脏病合并心力衰竭患者的管理。
Clin J Am Soc Nephrol. 2021 Jul;16(7):1131-1139. doi: 10.2215/CJN.14180920. Epub 2021 Jan 25.
8
Optimal Medical Therapy for Known Coronary Artery Disease: A Review.已知冠心病的最佳药物治疗:综述。
JAMA Cardiol. 2017 Sep 1;2(9):1030-1035. doi: 10.1001/jamacardio.2017.2249.
9
An evidence-based review of recent advances in therapy for heart failure with reduced ejection fraction (HFrEF).射血分数降低型心力衰竭(HFrEF)治疗的最新进展的循证综述。
Postgrad Med J. 2016 Dec;92(1094):726-734. doi: 10.1136/postgradmedj-2016-134378. Epub 2016 Oct 5.
10
Therapies for heart failure: a report from the Heart Failure Congress 2007.
Timely Top Med Cardiovasc Dis. 2007 Jul 13;11:E16.

引用本文的文献

1
Outcomes in diabetic vs nondiabetic patients requiring cardiac resynchronization therapy for heart failure: A meta-analysis.糖尿病患者与非糖尿病患者接受心力衰竭心脏再同步治疗的结局:一项荟萃分析。
Heart Rhythm O2. 2025 Mar 5;6(6):753-765. doi: 10.1016/j.hroo.2025.02.020. eCollection 2025 Jun.
2
Diabetes and risk of peripheral artery disease in patients undergoing first-time coronary angiography between 2000 and 2012 - a nationwide study.2000 年至 2012 年间首次接受冠状动脉造影术的患者中糖尿病与外周动脉疾病风险的关系——一项全国性研究。
BMC Cardiovasc Disord. 2019 Oct 24;19(1):234. doi: 10.1186/s12872-019-1213-1.
3
Anti-diabetic and anti-oxidative activity of fixed oil extracted from L. leaves in diabetic rats.
从L.叶中提取的固定油对糖尿病大鼠的抗糖尿病和抗氧化活性。
Exp Ther Med. 2016 Mar;11(3):832-840. doi: 10.3892/etm.2016.2991. Epub 2016 Jan 13.
4
Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: the RETAIN study.雷珠单抗0.5毫克治疗并延长方案用于糖尿病性黄斑水肿:RETAIN研究
Br J Ophthalmol. 2016 Jun;100(6):787-95. doi: 10.1136/bjophthalmol-2015-307249. Epub 2015 Oct 9.
5
Nigella sativa: A potential natural protective agent against cardiac dysfunction in patients with type 2 diabetes mellitus.黑种草:2型糖尿病患者心脏功能障碍的潜在天然保护剂。
J Family Community Med. 2015 May-Aug;22(2):88-95. doi: 10.4103/2230-8229.155380.
6
Pre-transplant diabetes mellitus is a risk factor for non-relapse mortality, especially infection-related mortality, after allogeneic hematopoietic SCT.移植前糖尿病是异基因造血干细胞移植后非复发死亡率的一个危险因素,尤其是与感染相关的死亡率。
Bone Marrow Transplant. 2015 Apr;50(4):553-8. doi: 10.1038/bmt.2014.315. Epub 2015 Jan 26.
7
Impact of diabetes mellitus on the clinical response to cardiac resynchronization therapy in elderly people.糖尿病对老年人心脏再同步治疗临床反应的影响。
J Cardiovasc Transl Res. 2014 Apr;7(3):362-8. doi: 10.1007/s12265-014-9545-9. Epub 2014 Feb 6.
8
The functional state of hormone-sensitive adenylyl cyclase signaling system in diabetes mellitus.糖尿病中激素敏感性腺苷酸环化酶信号系统的功能状态
J Signal Transduct. 2013;2013:594213. doi: 10.1155/2013/594213. Epub 2013 Sep 28.
9
Differences in traditional and non-traditional risk factors with special reference to nutritional factors in patients with coronary artery disease with or without diabetes mellitus.有或无糖尿病的冠心病患者传统和非传统风险因素的差异,特别提及营养因素。
Indian J Endocrinol Metab. 2013 Sep;17(5):844-50. doi: 10.4103/2230-8210.117235.